Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 4
1960 1
1961 1
1962 8
1963 5
1964 1
1965 6
1967 2
1968 6
1969 2
1971 3
1972 8
1973 1
1974 3
1975 5
1976 8
1977 3
1978 3
1979 4
1980 6
1981 4
1982 3
1983 1
1984 5
1985 10
1986 2
1987 9
1988 2
1989 6
1990 3
1991 6
1992 7
1993 3
1994 7
1995 3
1996 5
1997 10
1998 4
1999 3
2000 3
2001 1
2002 2
2003 5
2004 4
2005 5
2006 1
2009 3
2010 2
2011 4
2012 2
2013 1
2014 4
2015 2
2017 2
2018 2
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
Vision impairment therapies.
Renaud RC, Xuereb H. Renaud RC, et al. Nat Rev Drug Discov. 2003 Jun;2(6):425-6. doi: 10.1038/nrd1113. Nat Rev Drug Discov. 2003. PMID: 12790152 No abstract available.
Supporting US public health experts.
Cohen R, Francois C, Crowley J, Hastings P, King R, Love TW, Maraganore J, McMurry-Heath M, Levin J; Cosignatories. Cohen R, et al. Nat Biotechnol. 2020 Dec;38(12):1381-1384. doi: 10.1038/s41587-020-00767-6. Nat Biotechnol. 2020. PMID: 33239766 No abstract available.
Biotech leaders call for free press.
Cohen R, Holtzman S, Levin JM, Maraganore JM; Signatories to the Statement. Cohen R, et al. Nat Biotechnol. 2018 Oct 11;36(10):920-922. doi: 10.1038/nbt.4271. Nat Biotechnol. 2018. PMID: 30307914 No abstract available.
Erectile-dysfunction therapies.
Renaud RC, Xuereb H. Renaud RC, et al. Nat Rev Drug Discov. 2002 Sep;1(9):663-4. doi: 10.1038/nrd898. Nat Rev Drug Discov. 2002. PMID: 12216576 No abstract available.
US immigration order strikes against biotech.
Levin JM, Holtzman SH, Maraganore J, Hastings PJ, Cohen R, Dahiyat B, Adams J, Adams C, Ahrens B, Albers J, Aspinall MG, Audia JE, Babler M, Barrett P, Barry Z, Bermingham N, Bloch S, Blum RI, Bolno PB, Bonney MW, Booth B, Bradbury DM, Brauer SK, Byers B, Cagnoni PJ, Cali BM, Ciechanover I, Clark C, Clayman MD, Cleland JL, Cobb P, Cooper R, Currie MG, Diekman J, Dobmeier EL, Doerfler D, Donley EL, Dunsire D, During M, Eckstein JW, Elenko E, Exter NA, Fleming JJ, Flesher GJ, Formela JF, Forrester R, Francois C, Franklin H, Freeman MW, Furst H, Gage LP, Galakatos N, Gallagher BM, Geraghty JA, Gill S, Goeddel DV, Goldsmith MA, Gowen M, Goyal V, Graney T, Grayzel D, Greene B, Grint P, Gutierrez-Ramos JC, Haney B, Ha-Ngoc T, Harris T, Hasnain F, Hata YS, Hecht P, Henshaw L, Heyman R, Hoppenot H, Horvitz HR, Hughes TE, Hutton WS, Isaacs ST, Jenkins A, Jonker J, Kaplan J, Karsen P, Keiper J, Kim J, Kindler J, King R, King V, Kjellson N, Koenig S, Koenig G, Kolchinsky P, Laikind P, Langer RB, Lee JJ, Leff JS, Leicher BA, Leschly N, Levin A, Levin M, Levine AJ, Levy A, Liu DR, Lodish HF, Lopatin U, Love TW, Macdonald G, Maderis GJ, Mahadevia A, Mahanthappa NK, Martin JF, Martin A, Martucci… See abstract for full author list ➔ Levin JM, et al. Among authors: renaud rc. Nat Biotechnol. 2017 Mar 7;35(3):204-206. doi: 10.1038/nbt.3824. Nat Biotechnol. 2017. PMID: 28267733 No abstract available.
Author Correction: Supporting US public health experts.
Cohen R, Francois C, Crowley J, Hastings P, King R, Love TW, Maraganore J, McMurry-Heath M, Levin J; Cosignatories. Cohen R, et al. Nat Biotechnol. 2021 Jan;39(1):115. doi: 10.1038/s41587-020-00792-5. Nat Biotechnol. 2021. PMID: 33335308 No abstract available.
The fungal biocontrol agent Coniothyrium minitans: production by solid-state fermentation, application and marketing.
de Vrije T, Antoine N, Buitelaar RM, Bruckner S, Dissevelt M, Durand A, Gerlagh M, Jones EE, Lüth P, Oostra J, Ravensberg WJ, Renaud R, Rinzema A, Weber FJ, Whipps JM. de Vrije T, et al. Among authors: renaud r. Appl Microbiol Biotechnol. 2001 Jul;56(1-2):58-68. doi: 10.1007/s002530100678. Appl Microbiol Biotechnol. 2001. PMID: 11499948 Review.
Colorectal cancer market.
Smith RE, Renaud RC, Hoffman E. Smith RE, et al. Among authors: renaud rc. Nat Rev Drug Discov. 2004 Jun;3(6):471-2. doi: 10.1038/nrd1419. Nat Rev Drug Discov. 2004. PMID: 15214331 No abstract available.
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.
Afdhal NH, Zeuzem S, Schooley RT, Thomas DL, Ward JW, Litwin AH, Razavi H, Castera L, Poynard T, Muir A, Mehta SH, Dee L, Graham C, Church DR, Talal AH, Sulkowski MS, Jacobson IM; New Paradigm of HCV Therapy Meeting Participants. Afdhal NH, et al. J Viral Hepat. 2013 Nov;20(11):745-60. doi: 10.1111/jvh.12173. J Viral Hepat. 2013. PMID: 24168254 Free PMC article. Review.
218 results